JPH1135443A - Moisturizer, skin-roughening improving agent and skin lotion - Google Patents
Moisturizer, skin-roughening improving agent and skin lotionInfo
- Publication number
- JPH1135443A JPH1135443A JP20715097A JP20715097A JPH1135443A JP H1135443 A JPH1135443 A JP H1135443A JP 20715097 A JP20715097 A JP 20715097A JP 20715097 A JP20715097 A JP 20715097A JP H1135443 A JPH1135443 A JP H1135443A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- tetritol
- ether
- group
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 title claims description 17
- 239000004909 Moisturizer Substances 0.000 title abstract description 6
- 230000001333 moisturizer Effects 0.000 title abstract description 6
- 238000007788 roughening Methods 0.000 title description 6
- 239000006210 lotion Substances 0.000 title description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 89
- UNXHWFMMPAWVPI-UHFFFAOYSA-N butane-1,2,3,4-tetrol Chemical compound OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 65
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 36
- 238000006467 substitution reaction Methods 0.000 claims abstract description 28
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 35
- 206010013786 Dry skin Diseases 0.000 claims description 20
- 239000003906 humectant Substances 0.000 claims description 14
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 23
- 239000004386 Erythritol Substances 0.000 abstract description 20
- 235000019414 erythritol Nutrition 0.000 abstract description 20
- 229940009714 erythritol Drugs 0.000 abstract description 20
- 150000001875 compounds Chemical class 0.000 abstract description 14
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 abstract description 11
- 239000002904 solvent Substances 0.000 abstract description 8
- 239000003054 catalyst Substances 0.000 abstract description 4
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 229910052794 bromium Inorganic materials 0.000 abstract description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- -1 alkyl tetris Chemical compound 0.000 description 63
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 61
- 210000003491 skin Anatomy 0.000 description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
- 239000012071 phase Substances 0.000 description 37
- 239000000203 mixture Substances 0.000 description 31
- 239000003921 oil Substances 0.000 description 29
- 235000019441 ethanol Nutrition 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- 238000003756 stirring Methods 0.000 description 20
- 239000008346 aqueous phase Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 239000003755 preservative agent Substances 0.000 description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- ZBSLONNAPOEUFH-UHNVWZDZSA-N (2r,3s)-4-methoxybutane-1,2,3-triol Chemical compound COC[C@H](O)[C@H](O)CO ZBSLONNAPOEUFH-UHNVWZDZSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 229960000271 arbutin Drugs 0.000 description 12
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 12
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 12
- 230000002335 preservative effect Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 238000004945 emulsification Methods 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 235000011118 potassium hydroxide Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000000434 stratum corneum Anatomy 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000001273 butane Substances 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 6
- 229960004705 kojic acid Drugs 0.000 description 6
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- FJGNTEKSQVNVTJ-YZNZAMEGSA-N (2r,3r)-pentane-1,2,3,4-tetrol Chemical compound CC(O)[C@@H](O)[C@H](O)CO FJGNTEKSQVNVTJ-YZNZAMEGSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- FJGNTEKSQVNVTJ-KSFOROOFSA-N (2r,3s)-pentane-1,2,3,4-tetrol Chemical compound CC(O)[C@H](O)[C@H](O)CO FJGNTEKSQVNVTJ-KSFOROOFSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- FERWBXLFSBWTDE-UHFFFAOYSA-N 3-aminobutan-2-ol Chemical compound CC(N)C(C)O FERWBXLFSBWTDE-UHFFFAOYSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 229940055577 oleyl alcohol Drugs 0.000 description 3
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GXBYFVGCMPJVJX-UHFFFAOYSA-N Epoxybutene Chemical compound C=CC1CO1 GXBYFVGCMPJVJX-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 1
- KYEACNNYFNZCST-UHFFFAOYSA-N 1-methylpyrrolidine-2,5-dione Chemical compound CN1C(=O)CCC1=O KYEACNNYFNZCST-UHFFFAOYSA-N 0.000 description 1
- KYWXRBNOYGGPIZ-UHFFFAOYSA-N 1-morpholin-4-ylethanone Chemical compound CC(=O)N1CCOCC1 KYWXRBNOYGGPIZ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ZBSLONNAPOEUFH-UHFFFAOYSA-N 4-methoxybutane-1,2,3-triol Chemical compound COCC(O)C(O)CO ZBSLONNAPOEUFH-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- HLXLDBYTRSMNAI-UHFFFAOYSA-N C(C)(=O)OCC(C(COC)OC(C)=O)OC(C)=O Chemical compound C(C)(=O)OCC(C(COC)OC(C)=O)OC(C)=O HLXLDBYTRSMNAI-UHFFFAOYSA-N 0.000 description 1
- VBRIOQFOSCKZFN-UVCATTPVSA-N C(C)C([C@H](O)[C@H](O)CO)O Chemical compound C(C)C([C@H](O)[C@H](O)CO)O VBRIOQFOSCKZFN-UVCATTPVSA-N 0.000 description 1
- CRNHMMUWKVCQRK-UHFFFAOYSA-N C(C1=CC=CC=C1)C(=C(O)O)CC Chemical compound C(C1=CC=CC=C1)C(=C(O)O)CC CRNHMMUWKVCQRK-UHFFFAOYSA-N 0.000 description 1
- HIKVCEHZDUSXLU-VVXQKDJTSA-N C(CCC)C([C@H](O)[C@H](O)CO)O Chemical compound C(CCC)C([C@H](O)[C@H](O)CO)O HIKVCEHZDUSXLU-VVXQKDJTSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 241000694440 Colpidium aqueous Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- UNXHWFMMPAWVPI-IMJSIDKUSA-N L-threitol Chemical compound OC[C@H](O)[C@@H](O)CO UNXHWFMMPAWVPI-IMJSIDKUSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940105017 achillea millefolium extract Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940072065 ascorbic acid 2-sulfate Drugs 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- UCXAUVOTLFMULL-UHFFFAOYSA-N but-2-enyl propanoate Chemical compound CCC(=O)OCC=CC UCXAUVOTLFMULL-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規な保湿剤、肌
あれ改善剤、及びこれを配合した皮膚外用剤に関する。
更に詳しくは、安全性が高く、保湿効果及び肌あれ改善
効果に優れた低級アルキルテトリトールエーテルを有効
成分とする保湿剤及び肌あれ改善剤、並びにこれを配合
した保湿効果、肌あれ改善効果を有する皮膚外用剤に関
する。TECHNICAL FIELD The present invention relates to a novel moisturizing agent, skin roughness improving agent, and a skin external preparation containing the same.
More specifically, a moisturizer and a skin roughness improving agent containing a lower alkyl tetritol ether as an active ingredient, which is highly safe, has a superior moisturizing effect and a skin roughness improving effect, and a moisturizing effect and a skin roughness improving effect containing the same. And a skin external preparation.
【0002】[0002]
【従来の技術】従来、皮膚外用剤には、使用性・安全性
の向上、肌への刺激性低下、防腐等種々の目的で、例え
ば、ポリエチレングリコール、プロピレングリコール、
グルセリン、1,3-ブチレングリコール、キシリトール、
ソルビトール、マルチトール、コンドロイチン硫酸、ヒ
アルロン酸、ムコイチン硫酸、カロニン酸、アテロコラ
ーゲン、コレステリル-12-ヒドロキシステアレート、乳
酸ナトリウム、胆汁酸塩、dl- ピロリドンカルボン酸
塩、短鎖可溶性コラーゲン、ジグリセリン(EO)PO付加
物、イザヨイバラ抽出物、セイヨウノコギリソウ抽出
物、メリロート抽出物、等の保湿剤が配合されている。2. Description of the Related Art Conventionally, skin external preparations have been used for various purposes such as improvement of usability and safety, reduction of skin irritation, and preservation, for example, polyethylene glycol, propylene glycol, and the like.
Glycerin, 1,3-butylene glycol, xylitol,
Sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, diglycerin (EO ) Moisturizers such as PO adducts, Izayobara extract, Achillea millefolium extract, and melilot extract are incorporated.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、これら
の保湿剤の多くは、その機能に乏しく、期待できる効果
は必ずしも十分でなく、また、その化合物の種類によっ
ては、酸化安定性、匂い等の面において皮膚外用剤に使
用するためには問題があるものであった。However, many of these moisturizers have poor functions and the expected effects are not always sufficient, and depending on the type of the compound, the oxidative stability, odor, etc. However, there is a problem in using it for an external preparation for skin.
【0004】本発明者等は、このような事情に鑑み、真
に優れた保湿効果を有する皮膚外用剤を得るべく鋭意研
究を重ねた結果、化粧品原料としては使用されたことが
ない低級アルキルテトリトールエーテルに優れた保湿効
果及び肌あれ改善効果があることを発見し、これを皮膚
外用剤に配合すると、保湿効果に優れる上、更に肌改善
効果に優れた皮膚外用剤が得られることを見出し、本発
明を完成するに至った。In view of such circumstances, the present inventors have conducted intensive studies to obtain a skin external preparation having a truly excellent moisturizing effect. As a result, lower alkyl tetris which have never been used as a raw material for cosmetics are disclosed. We have discovered that tall ether has an excellent moisturizing effect and skin roughness improvement effect, and that when it is added to a skin external preparation, it is possible to obtain a skin external preparation that is excellent not only in moisturizing effect but also in skin improvement effect. Thus, the present invention has been completed.
【0005】本発明は、新規な保湿剤、肌あれ改善剤及
びこれを配合した保湿効果及び肌荒れ改善効果に優れた
皮膚外用剤を提供することを目的とする。An object of the present invention is to provide a novel moisturizing agent, a roughening agent, and a skin external preparation containing the same and having excellent moisturizing effects and skin roughness improving effects.
【0006】[0006]
【課題を解決するための手段】すなわち、本発明は、下
記一般式(1)で表される低級アルキルテトリトールエ
ーテルを有効成分とすることを特徴とする保湿剤を提供
するものである。That is, the present invention provides a humectant characterized by comprising a lower alkyl tetritol ether represented by the following general formula (1) as an active ingredient.
【化2】A−Rn (1) (Aは水素原子nを除いたテトリトール残基を表し、R
は炭素数1〜4のアルキル基で、直鎖アルキル基、分岐
アルキル基、不飽和アルキル基、ヒドロキシアルキル基
のいずれでも良い。nはRの平均置換度を表し、1〜4
の範囲の数である。)Embedded image A-Rn (1) (A represents a tetritol residue excluding a hydrogen atom n;
Is an alkyl group having 1 to 4 carbon atoms, and may be any of a linear alkyl group, a branched alkyl group, an unsaturated alkyl group, and a hydroxyalkyl group. n represents the average degree of substitution of R;
Is a number in the range. )
【0007】また、本発明は、上記の低級アルキルテト
リトールエーテルを有効成分とすることを特徴とする肌
あれ改善剤を提供するものである。The present invention also provides a skin roughness improving agent comprising the above lower alkyl tetritol ether as an active ingredient.
【0008】さらに、本発明は、上記の低級アルキルテ
トリトールエーテルを含有することを特徴とする皮膚外
用剤を提供するものである。[0008] The present invention further provides a skin external preparation characterized by containing the above-mentioned lower alkyl tetritol ether.
【0009】[0009]
【発明の実施の形態】以下、本発明の構成について詳述
する。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The configuration of the present invention will be described below in detail.
【0010】本発明に用いる低級アルキルテトリトール
エーテルは、保湿効果に優れ、肌荒れ改善効果を有し、
安全性及び酸化安定性に優れ、皮膚にも低刺激であると
いう特徴を有する。したがって、優れた保湿剤及び肌あ
れ改善剤として皮膚外用剤に用いることが出来る化合物
であり、従来、テトリトールの低級アルキルエーテルが
化粧料等の皮膚外用剤に配合されたことはなく、皮膚外
用剤の分野においては新規な原料化合物である。The lower alkyl tetritol ether used in the present invention has an excellent moisturizing effect, an effect of improving rough skin,
It is excellent in safety and oxidative stability, and is characterized by being less irritating to the skin. Therefore, it is a compound that can be used in an external preparation for skin as an excellent moisturizing agent and a skin roughness improving agent. Conventionally, a lower alkyl ether of tetritol has not been blended in an external preparation for skin such as cosmetics. In the field of 化合物, it is a new starting compound.
【0011】低級アルキルテトリトールエーテルを製造
するために用いるテトリトールとは、炭素数4のテトロ
ースの糖アルコールであり、例えば、エリスリトール、
D−トレイトール、L−トレイトールが挙げられる。[0011] Tetritol used for producing lower alkyl tetritol ether is a sugar alcohol of tetroses having 4 carbon atoms, for example, erythritol,
D-threitol and L-threitol.
【0012】本発明に用いる低級アルキルテトリトール
エーテルは、下記一般式(1)で表される。Aはテトリ
トールからn個の水素を除いた残基である。The lower alkyl tetritol ether used in the present invention is represented by the following general formula (1). A is a residue obtained by removing n hydrogen atoms from tetritol.
【化3】A−Rn (1)Embedded image A-Rn (1)
【0013】一般式(1)において、Aは、テトリトー
ルからn個の水素を除いた残基であり、Rは、炭素数1
〜4の脂肪鎖で、直鎖アルキル基、分岐アルキル基、不
飽和アルキル基、シクロアルキル基、ヒドロキシアルキ
ル基いずれでもよい。例えば、メチル基、エチル基、プ
ロピル基、ブチル基、イソプロピル基、s−ブチル基、
t−ブチル基、アリル基、2−ブテニル基、3−ブテニ
ル基、2−メチル2−プロペニル基、2,4−ビシクロ
プロピル基、シクロブチル基、2−メチルシクロプロピ
ル基、2−ヒドロキシエチル基、3−ヒドロキシプロピ
ル基、2−ヒドロキシプロピル基、2−ヒドロキシ1−
メチルエチル基、4−ヒドロキシブチル基、3−ヒドロ
キシブチル基、2−ヒドロキシブチル基、3−ヒドロキ
シ2−メチルプロピル基、2−ヒドロキシ2−メチルプ
ロピル基、2−ヒドロキシ1,1−ジメチルエチル基、
2,3−ジヒドロキシプロピル基、ビス(ヒドロキシメ
チル)メチル基、2,3−ジヒドロキシブチル基、2,
4−ジヒドロキシブチル基、3,4−ジヒドロキシブチ
ル基、2,3−ジヒドロキシ2−メチルプロピル基、3
−ヒドロキシ2−ヒドロキシメチルプロピル基、1,1
−ビス(ヒドロキシメチル)エチル基、トリス(ヒドロ
キシメチル)メチル基等が挙げられる。In the general formula (1), A is a residue obtained by removing n hydrogen atoms from tetritol, and R is a group having 1 carbon atom.
It may be any of a straight chain alkyl group, a branched alkyl group, an unsaturated alkyl group, a cycloalkyl group and a hydroxyalkyl group. For example, methyl group, ethyl group, propyl group, butyl group, isopropyl group, s-butyl group,
t-butyl group, allyl group, 2-butenyl group, 3-butenyl group, 2-methyl-2-propenyl group, 2,4-bicyclopropyl group, cyclobutyl group, 2-methylcyclopropyl group, 2-hydroxyethyl group, 3-hydroxypropyl group, 2-hydroxypropyl group, 2-hydroxy1-
Methylethyl group, 4-hydroxybutyl group, 3-hydroxybutyl group, 2-hydroxybutyl group, 3-hydroxy-2-methylpropyl group, 2-hydroxy-2-methylpropyl group, 2-hydroxy-1,1-dimethylethyl group ,
2,3-dihydroxypropyl group, bis (hydroxymethyl) methyl group, 2,3-dihydroxybutyl group, 2,
4-dihydroxybutyl group, 3,4-dihydroxybutyl group, 2,3-dihydroxy-2-methylpropyl group, 3
-Hydroxy-2-hydroxymethylpropyl group, 1,1
-Bis (hydroxymethyl) ethyl group, tris (hydroxymethyl) methyl group and the like.
【0014】テトリトールの4つの水酸基と低級アルキ
ル基のエーテル結合位置は、任意であり、いずれの位置
でも構わない。エーテル結合数は、水に対する溶解性の
点からモノエーテルが好ましいが、ジエーテル、トリエ
ーテル、テトラエーテルいずれの混合物でも構わない。
また、アルキル基がいずれか2種類以上の結合物でも構
わない。平均置換度nは、1〜4の範囲であるが、その
性状から、0.1〜2.8の範囲が好ましい。The position of the ether bond between the four hydroxyl groups and the lower alkyl group of tetritol is arbitrary and may be at any position. The number of ether bonds is preferably monoether from the viewpoint of solubility in water, but may be any mixture of diether, triether and tetraether.
Further, the alkyl group may be any two or more kinds of conjugates. The average degree of substitution n is in the range of 1 to 4, but is preferably in the range of 0.1 to 2.8 in view of its properties.
【0015】本発明の低級アルキルテトリトールエーテ
ルは、一般的なエーテル化反応により製造される。例え
ば、テトリトールをジメチルホルムアミド、ジメチルス
ルホキシド、ジオキサン、ジメチルアセトアミド、アセ
トン、N−メチルピロリドン、N−アセチルモルホリ
ン、N−メチルコハク酸イミド等の非水系溶媒に溶解す
るかもしくは無溶媒で、これに、一般式(2)The lower alkyl tetritol ether of the present invention is produced by a general etherification reaction. For example, tetritol is dissolved in a non-aqueous solvent such as dimethylformamide, dimethylsulfoxide, dioxane, dimethylacetamide, acetone, N-methylpyrrolidone, N-acetylmorpholine, N-methylsuccinimide, or in a solvent-free solvent. Equation (2)
【化4】X−R (2) (Rは、一般式(1)の定義と同様で、Xは、脱離基も
しくは水酸基であり、脱離基としては、例えば、臭素、
塩素、ヨウ素、メシル基、トシル基等が挙げられる。) 若しくは、一般式(3)Embedded image XR (2) (where R is the same as defined in the general formula (1), X is a leaving group or a hydroxyl group, and examples of the leaving group include bromine,
Examples thereof include chlorine, iodine, a mesyl group, and a tosyl group. Or the general formula (3)
【化5】 (もしくはR1 〜R4 の合計炭素数が2であるアルキル
基である。)で表される化合物を添加して、触媒の存在
下、0℃〜130℃で撹拌、反応させることにより得ら
れる。〔ロバートらの方法:Tetrahedron,
35,2169〜2172(1979)〕。Embedded image (Or an alkyl group having a total carbon number of R 1 to R 4 of 2), and the mixture is stirred and reacted at 0 ° C. to 130 ° C. in the presence of a catalyst. . [Robert et al .: Tetrahedron,
35, 2169-2172 (1979)].
【0016】上記の触媒としては、硫酸、塩酸、リン酸
等の酸、水酸化リチウム、水酸化ナトリウム、水酸化カ
リウム、金属ナトリウム等のアルカリ、ナトリウムメチ
ラート、ナトリウムエチラート等のナトリウムアルコラ
ート、N−メチルベンジルアミン等のアミン等が挙げら
れる。Examples of the above catalyst include acids such as sulfuric acid, hydrochloric acid and phosphoric acid, alkalis such as lithium hydroxide, sodium hydroxide, potassium hydroxide and metallic sodium, sodium alcoholates such as sodium methylate and sodium ethylate, N Amines such as -methylbenzylamine and the like.
【0017】この反応に使用される一般式(2)若しく
は一般式(3)で表される化合物のモル比は、本発明に
おいて好ましいモノエーテルを主生成物として得ようと
する場合には、1:1から3:1が好ましく、2:1〜
3:1が更に好ましい。テトリトールと一般式(1)若
しくは一般式(2)で示される化合物の比がこの範囲を
はずれる場合、すなわち、テトリトールが少ないとトリ
エーテルなどを生じ易く、テトリトール多すぎるとテト
リトールが多量に残って後の精製に支障をきたす。The molar ratio of the compound represented by the general formula (2) or (3) used in this reaction is 1 when the monoether preferred in the present invention is to be obtained as a main product. : 1 to 3: 1, preferably 2: 1 to 1
3: 1 is more preferred. When the ratio of tetritol to the compound represented by the general formula (1) or (2) is out of this range, that is, when the amount of tetritol is too small, triether or the like is easily generated. Hinders the purification of
【0018】一般式(2)若しくは一般式(3)で示さ
れる化合物がすべて消費された場合、反応系の触媒を中
和する目的で、酢酸、塩酸、硫酸、リン酸等の酸、水酸
化リチウム、水酸化ナトリウム、水酸化カリウム等のア
ルカリ、炭酸水素ナトリウム等の塩を加え、反応溶媒を
減圧留去する。若しくは、中和せずに精製をそのまま行
っても良い。When all the compounds represented by the general formula (2) or (3) are consumed, an acid such as acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid or the like is used for the purpose of neutralizing the catalyst of the reaction system. An alkali such as lithium, sodium hydroxide and potassium hydroxide, and a salt such as sodium hydrogen carbonate are added, and the reaction solvent is distilled off under reduced pressure. Alternatively, purification may be carried out without neutralization.
【0019】このようにして得られた反応生成物には、
低級アルキルテトリトールエーテルの他、塩、テトリト
ールが共存している。そのため、テトリトールと塩を除
去する場合、メチルアルコール、エチルアルコール、ブ
チルアルコール、イソプロピルアルコール等のエリスリ
トールを溶解しない溶媒で抽出したり、塩を多量に含む
水とメチルエチルケトン、n−ブタノールで分配し、有
機溶媒層を分取することにより精製できる。また、ハイ
パーポーラスポリマー(例えば三菱化学株式会社製のハ
イポーラス樹脂)、オクタデシルシリカなどの逆層分配
カラムやシリカゲルカラムなどにより精製することも可
能である。The reaction product thus obtained includes:
A salt and tetritol coexist in addition to the lower alkyl tetritol ether. Therefore, when removing tetritol and salts, extraction with a solvent that does not dissolve erythritol such as methyl alcohol, ethyl alcohol, butyl alcohol, and isopropyl alcohol, or partition with water containing a large amount of salt, methyl ethyl ketone, and n-butanol, It can be purified by separating the solvent layer. In addition, it is also possible to purify using a reverse layer distribution column such as a hyperporous polymer (for example, a high porous resin manufactured by Mitsubishi Chemical Corporation), octadecyl silica, or a silica gel column.
【0020】上記のように合成した低級アルキルテトリ
トールエーテルは、抽出溶媒を留去したり、カラムによ
り精製した後に用いてもよく、また、特に精製せずにそ
のまま用いることも出来る。The lower alkyl tetritol ether synthesized as described above may be used after distilling off the extraction solvent or purifying it with a column, or may be used without any particular purification.
【0021】また、本発明に用いる低級アルキルテトリ
トールエーテルは、テトリトールに他の化合物により保
護基を施したり、誘導体とすることによって、目的のエ
ーテル置換度を有する低級アルキルテトリトールエーテ
ルを得ることができる。The lower alkyl tetritol ether used in the present invention can be a derivative of a lower alkyl tetritol ether having a desired degree of ether substitution by subjecting tetritol to a protecting group with another compound or a derivative. it can.
【0022】例えば、モノエーテルを得ようとした場
合、以下のような合成でも得られる。すなわち、1,3
−ブタジエンモノエポシドを、一般式(4)For example, when trying to obtain a monoether, it can also be obtained by the following synthesis. That is, 1,3
-Butadiene monoeposide is represented by the general formula (4)
【化6】ZーOR (4) (Rは、一般式1の定義と同様。Zは、ナトリウム、カ
リウム等の金属。)で表される求核試薬と反応させて、
一般式(5)若しくは一般式(6)## STR6 ## Z-OR (4) (R is the same as defined in the general formula 1. Z is a metal such as sodium or potassium.)
General formula (5) or General formula (6)
【化7】 RO−CH2−CHOH−CH=CH2 (5)Embedded image RO—CH 2 —CHOH—CH = CH 2 (5)
【化8】 HO−CH2−CHOR−CH=CH2 (6) (Rは一般式(1)の定義と同様。)のような化合物に
誘導し、その後、二重結合部をエポキシ化した後に開環
ジオール化したり、また、直接ジオール化することによ
り目的の低級アルキルテトリトールエーテルを得ること
ができる。また、1,3−ブタジエンモノエポキシドの
エポキシ基を開環ジオール化した後に二重結合部をエポ
キシ化し、一般式(4)で表される求核試薬と反応させ
ることにより目的の化合物を得ることができ、開環ジオ
ール化した化合物をエーテル化した後に二重結合部をジ
オール化することにより得ることもできる。Embedded image A compound such as HO—CH 2 —CHOR—CH = CH 2 (6) (where R is the same as defined in the general formula (1)) was obtained, and then the double bond was epoxidized. The desired lower alkyl tetritol ether can be obtained by ring-opening diol later or by direct diolation. Further, the desired compound is obtained by subjecting the epoxy group of 1,3-butadiene monoepoxide to ring-opening diol and then epoxidizing the double bond and reacting with a nucleophile represented by the general formula (4). The compound can also be obtained by etherifying a ring-opened diol compound and then diolating the double bond.
【0023】また、cis2−ブテン−1,4−ジオー
ルをモノアシル酸エステル化し、更にベンジル化した後
に脱アシル化し、得られたモノベンジルブテンジオール
を低級アルキルエーテル化し、得られた化合物の二重結
合部をジオール化し、脱ベンジル化を行うことにより、
本発明に用いる低級アルキルテトリトールエーテルを得
ることができる。この場合、保護基はベンジル基に限ら
ず、酸・アルカリ下に耐えうる結合であれば他の化合物
でも構わない。Further, cis 2-butene-1,4-diol is converted into a monoacyl ester, further benzylated and then deacylated, and the resulting monobenzylbutene diol is converted into a lower alkyl ether to form a double bond of the obtained compound. Part by diolation and debenzylation,
The lower alkyl tetritol ether used in the present invention can be obtained. In this case, the protecting group is not limited to a benzyl group, and other compounds may be used as long as the bond can withstand acid and alkali.
【0024】上記低級アルキルテトリトールエーテルは
保湿効果及び肌あれ改善効果を有し、これを実質的に有
効成分とする保湿剤または肌あれ改善剤が提供でき、そ
の一種または二種以上を配合して、保湿効果又は肌あれ
改善効果を有する本発明の皮膚外用剤が提供される。The lower alkyl tetritol ether has a moisturizing effect and a roughening effect, and can provide a moisturizing agent or a roughening agent containing the same as an effective ingredient. Thus, the skin external preparation of the present invention having a moisturizing effect or a skin roughness improving effect is provided.
【0025】本発明に係る皮膚外用剤に配合される低級
アルキルテトリトールエーテルの配合量は特に限定され
ないが、一般には、皮膚外用剤全量に対して、0.00
1〜20重量%、好ましくは、0.01〜15重量%、
特に好ましくは、0.1〜10重量%配合する。配合量
が0.001重量%未満では皮膚外用剤の肌改善効果乏
しくなる傾向にあり、逆に、20重量%を超えて配合し
ても効果の増加は実質上望めないし、皮膚外用剤への配
合も難しくなる傾向にある。The amount of the lower alkyl tetritol ether to be added to the external preparation for skin according to the present invention is not particularly limited.
1 to 20% by weight, preferably 0.01 to 15% by weight,
Particularly preferably, the content is 0.1 to 10% by weight. If the amount is less than 0.001% by weight, the effect of the external preparation for skin tends to be poor, and if the amount exceeds 20% by weight, the effect cannot be substantially increased, and Formulation also tends to be difficult.
【0026】本発明の皮膚外用剤には、上記した必須成
分の他に通常化粧品や医薬品等の皮膚外用剤に用いられ
る他の成分、例えば、油分、湿潤剤、紫外線吸収剤、酸
化防止剤、界面活性剤、防腐剤、他の保湿剤、香料、色
料、水、アルコール、増粘剤、高分子、粉末、薬剤、キ
レート剤、植物抽出物等を必要に応じて適宜配合するこ
とができる。The external preparation for skin of the present invention includes, in addition to the above essential components, other components usually used in external preparations for skin such as cosmetics and pharmaceuticals, such as oils, wetting agents, ultraviolet absorbers, antioxidants, Surfactants, preservatives, other humectants, fragrances, colorants, water, alcohols, thickeners, polymers, powders, drugs, chelating agents, plant extracts, etc. can be appropriately compounded as necessary. .
【0027】本発明の皮膚外用剤の剤型は任意であり、
溶液系、可溶化系、乳化系、油液系、ゲル系、粉末分散
系、水−油二層系、水−油−粉末三層系等、目的とする
製品に応じて本発明の必須成分と上記の任意配合成分と
を配合して常法により製造することが出来る。The dosage form of the external preparation for skin of the present invention is arbitrary,
The essential components of the present invention depending on the target product, such as a solution system, a solubilizing system, an emulsifying system, an oil-liquid system, a gel system, a powder dispersion system, a water-oil two-layer system, a water-oil-powder three-layer system, etc. And the above-mentioned optional components can be blended to produce the compound by a conventional method.
【0028】本発明の皮膚外用剤とは、化粧料、医薬
品、医薬部外品として、外皮(頭皮を含む)に適用され
るものを指し、例えば、化粧水、乳液、クリーム、パッ
ク等のフェーシャル化粧料やファンデーション、口紅、
アイシャドー等のメーキャップ化粧料やボディー化粧
料、芳香化粧料、頭皮頭髪化粧料、洗浄料、軟膏等に用
いることができる。The skin external preparation of the present invention refers to those applied to the outer skin (including the scalp) as cosmetics, pharmaceuticals, and quasi-drugs, and includes, for example, facials such as lotions, emulsions, creams, and packs. Cosmetics, foundation, lipstick,
It can be used for makeup cosmetics such as eye shadows, body cosmetics, aromatic cosmetics, scalp hair cosmetics, cleaning agents, ointments and the like.
【0029】[0029]
【実施例】次に実施例をあげて本発明をさらに詳しく説
明する。本発明はこれによって限定されるものではな
い。配合量はすべて重量%である。Next, the present invention will be described in more detail by way of examples. The present invention is not limited by this. All amounts are by weight.
【0030】先ず、本発明に用いる低級アルキルテトリ
トールエーテルの合成例について詳述する。First, a synthesis example of the lower alkyl tetritol ether used in the present invention will be described in detail.
【0031】「合成例1:モノメチルエリスリトールエ
ーテルの合成」 (1,2,3−トリヒドロキシ−4−メトキシ−ブタ
ン)シス2−ブテン−1,4−ジオール73.4g
(0.6mol)を予め乾燥しておいたアセトン240
mlに溶解し、無水プロピオン酸78ml(0.6mo
l)を加えて加熱還流15時間行った。室温にて空冷
後、減圧濃縮し、酢酸エチル500mlにて抽出し、精
製水にて3回洗浄し、無水硫酸マグネシウムにて乾燥
後、減圧濃縮し、得られた濃縮物をシリカゲルカラムク
ロマトグラフ法にて精製し、無色オイル状のモノプロピ
オン酸シス2−ブテン−1,4−ジオールエステルを3
8.1g(収率43.4%)得た。得られたモノプロピ
オン酸シス2−ブテン−1,4−ジオールエステル3
8.1g(264mmol)を予め乾燥しておいたジメ
トキシエタン150mlに溶解し、水素化ナトリウム2
6.4g(396mmol、60%純度)を予めヘキサ
ンにて洗浄し、減圧乾燥しておいてから加え、30分間
室温にて撹拌した。臭化ベンジル67.85g(291
mmol)を加え、室温にて3時間撹拌した。メタノー
ル100mlを加えて反応を停止し、減圧濃縮した後、
酢酸エチル500mlにて抽出し、精製水にて3回洗浄
した。無水硫酸マグネシウムにて乾燥、ろ過した後、減
圧濃縮し、無色オイル状の粗1−ベンジロキシ−シス2
−ブテニルプロピオネイトを得た。得られた粗1−ベン
ジロキシ−シス2−ブテニルプロピオネイトをメタノー
ル300mlに溶解し、ナトリウムメチラートメタノー
ル溶液(和光純薬製)30mlを加え、1晩加熱還流し
た。減圧濃縮した後、酢酸エチル500mlにて抽出
し、精製水にて2回洗浄した。無水硫酸マグネシウムに
て乾燥した後、ろ過し、減圧濃縮して得られた濃縮物を
シリカゲルカラムクロマトグラフ法にて精製し、無色オ
イル状の1−ベンジロキシ−シス2−ブテン−4−オー
ルを36.8g(78.3%;モノプロピオン酸シス2
−ブテン−1,4−ジオールエステルからのトータル収
率)を得た。得られた1−ベンジロキシ−シス2−ブテ
ン−4−オールを30.1g(169mmol)をジメ
チルスルフォキシド200mlに溶解し、水酸化カリウ
ム28.4g(422mmol)を加えた後、撹拌しな
がら、ヨウ化メチル67g(472mmol)を加え、
室温にて5時間撹拌した。酢酸エチル500mlにて抽
出し、精製水にて1回洗浄した。無水硫酸マグネシウム
にて乾燥、ろ過した後、減圧濃縮し、得られた濃縮物を
シリカゲルカラムクロマトグラフ法にて精製し、無色オ
イル状の1−ベンジロキシ−4−メトキシ−シス2−ブ
テン30.7g(収率94.9%)を得た。得られた1
−ベンジロキシ−4−メトキシ−シス2−ブテン30.
7g(160mmol)をクロロホルム300mlに溶
解し、mCPBA55.2g(320mmol)を加
え、室温にて1晩撹拌した。減圧濃縮し、酢酸エチル5
00mlにて抽出し、10%チオ硫酸ナトリウム水溶液
にて1回、飽和炭酸水素ナトリウム水溶液で1回、精製
水にて1回洗浄した。無水硫酸マグネシウムにて乾燥、
ろ過した後、減圧濃縮し、得られた濃縮物をシリカゲル
カラムクロマトグラフ法にて精製し、無色シロップ状の
1−ベンジロキシ−2−エポキシ−4−メトキシ−ブタ
ン30.4g(収率91.2%)を得た。得られた1−
ベンジロキシ−2−エポキシ−4−メトキシ−ブタン3
0.4g(146mmol)を10%含水ジメチルスル
フォキシド200mlに溶解し、予め乳鉢にて粉砕して
おいた水酸化カリウム14g(248mmol)を加
え、100℃にて8時間撹拌した。室温にて空冷後、酢
酸エチル500mlにて抽出し、精製水にて1回洗浄し
た。無水硫酸マグネシウムにて乾燥、ろ過した後、減圧
濃縮し、得られた濃縮物をシリカゲルクロマトグラフ法
にて精製し、無色シロップ状の1−ベンジロキシ2,3
−ジヒドロキシ−4−メトキシブタンを28.7g(収
率87.0%)得た。1−ベンジロキシ2,3−ジヒド
ロキシ−4−メトキシブタン31.0g(137mmo
l)をエタノール200mlに溶解し、10%パラジウ
ム炭素をスパチュラ2杯、濃塩酸6滴を加え、水素下室
温にて撹拌した。水素約31lを消費し、ろ過した。炉
液を減圧濃縮し、減圧乾燥して無色シロップ状の粗1−
メトキシ−2,3,4−トリヒドロキシ−ブタンを得
た。得られた粗1−メトキシ−2,3,4−トリヒドロ
キシ−ブタンを定法にてアセチル化し、シロップ状の
1,2,3−トリアセトキシ−4−メトキシ−ブタン2
8.7g(87.0%;1−ベンジロキシ−2−エポキ
シ−4−メトキシ−ブタンのトータル収率)を得た。得
られた1,2,3−トリアセトキシ−4−メトキシ−ブ
タンの分析値を以下に示す。1 H−NMR(CD3OD,TMS,ppm) 5.3、5.2、4.3、4.1、3.5、3.3、
2.1、2.1、2.0 13 C− NMR(CD致さんOD,TMS,ppm) δ170.5、170.1、170.0、70.7、7
0.2、70.0、62.1、62.0、59.2、2
1.0、20.7 得られた1,2,3−トリアセトキシ−4−メトキシ−
ブタン22.71gを定法にて脱アセチル化し、オイル
状のエリスリトールモノメチルエーテル(1,2,3−
トリヒドロキシ−4−メトキシ−ブタン)を11.5g
(収率97.5%)を得た。得られたエリスリトールモ
ノメチルエーテルの分析値を以下に示す。 GC/MSD(TMS化処理、m/Z) 307、147、103、731 H−NMR(CD3 OD,TMS,ppm) 2.0〜1.98(m)13 C−NMR(CD3 OD,TMS,ppm) δ56.1、61.1、68.0、70.1、72.0"Synthesis Example 1: Monomethylerythritol E
(1,2,3-trihydroxy-4-methoxy-buta)
N) 73.4 g of cis 2-butene-1,4-diol
(0.6 mol) acetone 240 previously dried
and dissolved in 78 ml of propionic anhydride (0.6 mol).
l) was added and the mixture was heated under reflux for 15 hours. Air cooling at room temperature
Then, the mixture was concentrated under reduced pressure, extracted with 500 ml of ethyl acetate, and purified.
Wash 3 times with water making and dry with anhydrous magnesium sulfate
Then, the mixture is concentrated under reduced pressure.
Purified by a chromatographic method, the colorless oily monopropyl
Onic acid cis 2-butene-1,4-diol ester was added to 3
8.1 g (43.4% yield) was obtained. The monoprop obtained
Acid cis 2-butene-1,4-diol ester 3
8.1 g (264 mmol) of dried
Dissolve in 150 ml of toxicethane and add sodium hydride 2
6.4 g (396 mmol, 60% purity)
After washing under vacuum and drying under reduced pressure, add for 30 minutes
Stir at room temperature. 67.85 g of benzyl bromide (291
mmol) and stirred at room temperature for 3 hours. Methaneau
The reaction was stopped by adding 100 ml of toluene and concentrated under reduced pressure.
Extract with 500 ml of ethyl acetate and wash three times with purified water
did. After drying and filtering with anhydrous magnesium sulfate,
Concentrated to give a colorless oily crude 1-benzyloxy-cis 2
-Butenyl propionate was obtained. The crude 1-ben obtained
Diloxy-cis 2-butenyl propionate was converted to methanol
Dissolved in 300 ml of sodium methylate methanol
Solution (manufactured by Wako Pure Chemical Industries, Ltd.) and heat to reflux overnight.
Was. After concentration under reduced pressure, extract with 500 ml of ethyl acetate
And washed twice with purified water. To anhydrous magnesium sulfate
After drying, the mixture was filtered and concentrated under reduced pressure.
Purified by silica gel column chromatography, colorless
Ill-form 1-benzyloxy-cis 2-buten-4-o
36.8 g (78.3%; cis monopropionate 2)
-Total yield from butene-1,4-diol ester
Rate). 1-benzyloxy-cis 2-bute obtained
30.1 g (169 mmol) of di-4-ol
Dissolve in 200 ml of tyl sulfoxide, and add potassium hydroxide
After addition of 28.4 g (422 mmol) of
Then, 67 g (472 mmol) of methyl iodide was added,
Stirred at room temperature for 5 hours. Extract with 500 ml of ethyl acetate
And washed once with purified water. Anhydrous magnesium sulfate
After drying and filtration at, the mixture was concentrated under reduced pressure.
Purified by silica gel column chromatography, colorless
I-like 1-benzyloxy-4-methoxy-cis 2-bu
30.7 g (94.9% yield) of ten were obtained. 1 obtained
-Benzyloxy-4-methoxy-cis 2-butene 30.
7 g (160 mmol) dissolved in 300 ml of chloroform
And 55.2 g (320 mmol) of mCPBA was added.
And stirred at room temperature overnight. Concentrate under reduced pressure and add ethyl acetate 5
Extract with 100ml, 10% sodium thiosulfate aqueous solution
Once, and once with saturated aqueous sodium hydrogen carbonate solution
Washed once with water. Dried over anhydrous magnesium sulfate,
After filtration, the mixture was concentrated under reduced pressure.
Purified by column chromatography to give a colorless syrup
1-benzyloxy-2-epoxy-4-methoxy-buta
30.4 g (91.2% yield) were obtained. The obtained 1-
Benzyloxy-2-epoxy-4-methoxy-butane 3
0.4 g (146 mmol) of 10% aqueous dimethyl sulf
Dissolve in 200 ml of foxide and crush in advance in a mortar
14 g (248 mmol) of potassium hydroxide
Then, the mixture was stirred at 100 ° C. for 8 hours. Vinegar after air cooling at room temperature
Extract with 500 ml of ethyl acid and wash once with purified water
Was. After drying over anhydrous magnesium sulfate and filtration, the pressure was reduced.
Concentrate and concentrate the resulting concentrate on silica gel chromatography.
1-benzyloxy 2,3 in the form of a colorless syrup
28.7 g of dihydroxy-4-methoxybutane (yield
Rate of 87.0%). 1-benzyloxy 2,3-dihydride
Roxy-4-methoxybutane 31.0 g (137 mmol
l) was dissolved in 200 ml of ethanol, and 10%
2 spatulas of carbon and 6 drops of concentrated hydrochloric acid
Stirred at warm. About 31 l of hydrogen was consumed and filtered. Furnace
The solution was concentrated under reduced pressure and dried under reduced pressure to give a colorless syrupy crude 1-
Methoxy-2,3,4-trihydroxy-butane is obtained.
Was. The obtained crude 1-methoxy-2,3,4-trihydro
Xy-butane is acetylated by a conventional method, and syrupy
1,2,3-triacetoxy-4-methoxy-butane 2
8.7 g (87.0%; 1-benzyloxy-2-epoxy)
(Total yield of ci-4-methoxy-butane). Profit
1,2,3-triacetoxy-4-methoxy-butyl
The analytical values of the tan are shown below.1 H-NMR (CDThreeOD, TMS, ppm) 5.3, 5.2, 4.3, 4.1, 3.5, 3.3,
2.1, 2.1, 2.0 13 C- NMR (CD OD, TMS, ppm) δ 170.5, 170.1, 170.0, 70.7, 7
0.2, 70.0, 62.1, 62.0, 59.2, 2
1.0, 20.7 The resulting 1,2,3-triacetoxy-4-methoxy-
22.71 g of butane is deacetylated by a conventional method, and oil
Erythritol monomethyl ether (1,2,3-
11.5 g of trihydroxy-4-methoxy-butane)
(Yield 97.5%). The obtained erythritol mo
The analytical values of nomethyl ether are shown below. GC / MSD (TMS processing, m / Z) 307, 147, 103, 731 H-NMR (CD3 OD, TMS, ppm) 2.0-1.98 (m)13 C-NMR (CD3 OD, TMS, ppm) δ 56.1, 61.1, 68.0, 70.1, 72.0
【0032】「合成例2:メチルエリスリトールエーテ
ルの合成」エリスリトール10g(82mmol)を無
水ジメチルスルフォキシド100mlに溶解し、粉砕し
た水酸化ナトリウム3.3g(82mmol)を加え、
ヨウ化メチル11.6g(82mmol)を撹拌下、順
次滴下した。1晩室温にて撹拌した後、塩酸を加え反応
系を中和した後、溶媒を減圧留去し、メタノール200
mlで抽出した。得られたメタノール層を減圧濃縮し、
メチルエリスリトールエーテル4.5g(平均置換度
n;1.3)を得た。"Synthesis Example 2: Synthesis of methyl erythritol ether" 10 g (82 mmol) of erythritol was dissolved in 100 ml of anhydrous dimethyl sulfoxide, and 3.3 g (82 mmol) of pulverized sodium hydroxide was added.
11.6 g (82 mmol) of methyl iodide was added dropwise with stirring. After stirring overnight at room temperature, hydrochloric acid was added to neutralize the reaction system, and the solvent was distilled off under reduced pressure.
Extracted in ml. The obtained methanol layer was concentrated under reduced pressure,
4.5 g of methyl erythritol ether (average degree of substitution n: 1.3) was obtained.
【0033】「合成例3:メチルトレオトールエーテル
の合成」トレオトール10g(82mol)を無水ジメ
チルスルフォキシド100mlに溶解し、粉砕した水酸
化ナトリウム3.3g(82mmol)を加え、ヨウ化
メチル11.6g(82mmol)を撹拌下、順次滴下
した。1晩室温にて撹拌した後、塩酸を加え反応系を中
和した後、溶媒を減圧留去し、メタノール200mlで
抽出した。得られたメタノール層を減圧濃縮し、メチル
トレオトールエーテル4.3g(平均置換度n;1.
5)を得た。"Synthesis Example 3: Synthesis of methyl threitol ether" 10 g (82 mol) of threitol was dissolved in 100 ml of anhydrous dimethyl sulfoxide, and 3.3 g (82 mmol) of pulverized sodium hydroxide was added. 6 g (82 mmol) were sequentially added dropwise with stirring. After stirring at room temperature overnight, hydrochloric acid was added to neutralize the reaction system, and then the solvent was distilled off under reduced pressure and extracted with 200 ml of methanol. The obtained methanol layer was concentrated under reduced pressure, and 4.3 g of methylthreitol ether (average degree of substitution n;
5) was obtained.
【0034】「合成例4:エチルエリスリトールエーテ
ルの合成」エリスリトール10g(82mol)を無水
ジメチルスルフォキシド90mlに溶解し、粉砕した水
酸化ナトリウム3.3g(82mmol)を加え、ヨウ
化エチル12.8g(82mmol)を撹拌下、順次滴
下した。1晩室温にて撹拌した後、塩酸を加え反応系を
中和した後、溶媒を減圧留去し、メタノール200ml
で抽出した。得られたメタノール層を減圧濃縮し、エチ
ルエリスリトールエーテル5.0g(平均置換度n;
1.2)を得た。Synthesis Example 4: Synthesis of ethyl erythritol ether 10 g (82 mol) of erythritol was dissolved in 90 ml of anhydrous dimethyl sulfoxide, 3.3 g (82 mmol) of ground sodium hydroxide was added, and 12.8 g of ethyl iodide was added. (82 mmol) were added dropwise with stirring. After stirring at room temperature overnight, hydrochloric acid was added to neutralize the reaction system, and the solvent was distilled off under reduced pressure.
Extracted. The obtained methanol layer was concentrated under reduced pressure, and 5.0 g of ethyl erythritol ether (average degree of substitution n;
1.2) was obtained.
【0035】「合成例5:エチルトレオトールエーテル
の合成」トレオトール10g(82mol)にエタノー
ル30ml、粉砕した水酸化ナトリウム3.3g(82
mmol)を加え、加熱した。反応後、メタノールで抽
出し、得られたメタノール層を減圧濃縮し、メチルトレ
オトールエーテル4.8g(平均置換度n;1.3)を
得た。"Synthesis Example 5: Synthesis of ethyl threitol ether" 30 g of ethanol was added to 10 g (82 mol) of threitol, and 3.3 g of ground sodium hydroxide (82 g)
mmol) and heated. After the reaction, the reaction mixture was extracted with methanol, and the obtained methanol layer was concentrated under reduced pressure to obtain 4.8 g of methylthreitol ether (average degree of substitution n: 1.3).
【0036】「合成例6:メチルトレオトールエーテル
及びメチルエリスリトールエーテル混合物の合成」1,
3−ブタジエンモノエポキシド10g(144mmo
l)をジメチルスルフォキシド20mlに溶解し、ナト
リウムメチラート9.3g(171mmol)、塩化ア
ンモニウム9.9g(186mmol)を加え、90℃
閉鎖系にて撹拌した。反応後、酢酸エチル200mlに
て抽出、減圧濃縮し、得られた濃縮物をクロロホルム2
00mlに溶解し、mCPBA49.7g(288mm
ol)を加えて室温にて1晩撹拌した。減圧濃縮し、酢
酸エチル300mlにて抽出し、10%チオ硫酸ナトリ
ウム水溶液にて1回、飽和炭酸水素ナトリウム水溶液で
1回、精製水にて1回洗浄した。無水硫酸マグネシウム
にて乾燥、ろ過した後、減圧濃縮し、得られた濃縮物を
10%含水ジメチルスルフォキシド200mlに溶解
し、予め乳鉢にて粉砕しておいた水酸化カリウム7g
(124mmol)を加え、100℃にて4時間撹拌し
た。室温にて空冷後、塩酸にて中和し、減圧濃縮し、定
法にてアセチル化して、1,2,3−トリアセトキシ−
4−メトキシ−ブタン21.5g(57.0%;1,3
−ブタジエンモノエポキシドのトータル収率)を得た。
得られた1,2,3−トリアセトキシ−4−メトキシ−
ブタン21.5gを定法にて脱アセチル化し、メチルト
レオトールエーテル及びメチルエリスリトールエーテル
混合物(1,2,3−トリヒドロキシ−4−メトキシ−
ブタン)を10.8g(収率96.5%)を得た。"Synthesis Example 6: Synthesis of a mixture of methyl threitol ether and methyl erythritol ether" 1,
10 g of 3-butadiene monoepoxide (144 mmo
l) was dissolved in 20 ml of dimethyl sulfoxide, 9.3 g (171 mmol) of sodium methylate and 9.9 g (186 mmol) of ammonium chloride were added, and 90 ° C.
The mixture was stirred in a closed system. After the reaction, the reaction mixture was extracted with 200 ml of ethyl acetate and concentrated under reduced pressure.
And dissolved in 4 ml of mCPBA (288 mm
ol) and stirred at room temperature overnight. The mixture was concentrated under reduced pressure, extracted with 300 ml of ethyl acetate, and washed once with a 10% aqueous sodium thiosulfate solution, once with a saturated aqueous sodium hydrogen carbonate solution, and once with purified water. After drying and filtering over anhydrous magnesium sulfate, the solution was concentrated under reduced pressure, and the obtained concentrate was dissolved in 200 ml of 10% aqueous dimethyl sulfoxide, and 7 g of potassium hydroxide previously ground in a mortar.
(124 mmol) and stirred at 100 ° C. for 4 hours. After air cooling at room temperature, the mixture was neutralized with hydrochloric acid, concentrated under reduced pressure, acetylated by a conventional method, and 1,2,3-triacetoxy-
21.5 g of 4-methoxy-butane (57.0%; 1,3
-Butadiene monoepoxide total yield).
The obtained 1,2,3-triacetoxy-4-methoxy-
21.5 g of butane was deacetylated by a conventional method, and a mixture of methylthreitol ether and methylerythritol ether (1,2,3-trihydroxy-4-methoxy-) was obtained.
Butane) was obtained in an amount of 10.8 g (yield 96.5%).
【0037】次に本発明の効果試験方法および評価方法
について説明する。以下の方法で、肌に対する保湿効果
および肌あれ改善効果を評価した。Next, the effect test method and the evaluation method of the present invention will be described. The moisturizing effect on skin and the effect of improving rough skin were evaluated by the following methods.
【0038】「水分蒸発速度による保湿効果の測定」保
湿剤の保湿効果を測定する試験として、表1に示す試料
について水分蒸発速度の測定を行った。すなわち、2.0
×2.0cm の濾紙上に10μlの試験液を滴下後、1分ご
とにその重量減少を10分間測定し、1分あたりに減少
する重量を求めた。なお、保湿剤は、乾燥残分を水に溶
解し、5%に調整したものを試料溶液とした。対象とし
ては、蒸留水を用いた。以下の判定基準で保湿効果を評
価し、その結果を表2に示した。表2より明らかなよう
に、従来の保湿剤の比較例に比べて、本発明の保湿剤で
ある実施例の方が優れた保湿効果を有することが認めら
れた。 (判定基準) ◎:水分蒸発速度 0.50μg/min.以下 ○:水分蒸発速度 0.50〜0.55μg/min. △:水分蒸発速度 0.55〜0.60μg/min. ×:水分蒸発速度 0.60μg/min.以上"Measurement of Moisturizing Effect by Moisture Evaporation Rate" As a test for measuring the moisturizing effect of the humectant, the samples shown in Table 1 were measured for the moisture evaporation rate. That is, 2.0
After dropping 10 μl of the test solution onto a × 2.0 cm 2 filter paper, the weight loss was measured every minute for 10 minutes, and the weight loss per minute was determined. The humectant was prepared by dissolving the dried residue in water and adjusting the concentration to 5% as a sample solution. Distilled water was used as a target. The moisturizing effect was evaluated according to the following criteria, and the results are shown in Table 2. As is clear from Table 2, it was confirmed that the example of the humectant of the present invention had a better moisturizing effect than the comparative example of the conventional humectant. (Criterion criteria) A: Water evaporation rate 0.50 μg / min. Less than ○: Water evaporation rate 0.50 to 0.55 μg / min. Δ: Water evaporation rate 0.55 to 0.60 μg / min. ×: Water evaporation rate 0.60 μg / min. that's all
【0039】[0039]
【表1】 [Table 1]
【0040】[0040]
【表2】 [Table 2]
【0041】「肌保湿効果テスト」男女各20人のパネ
ルを用いて肌に対する保湿効果を評価した。評価方法
は、上腕部を洗浄したのちに試料を塗布し、下記の通
り、試験前のTWL及び肌コンダクタンス値の変化を測
定して、肌の保湿効果をテストした。以下の評価基準に
より評価を行い、その結果を表3に示した。表3より明
らかなように、従来の保湿剤の比較例に比べて、本発明
の保湿剤である実施例の方が優れた肌の保湿効果を有す
ることが認められた。 コンダクタンス変化率=コンダクタンスの変化量/使用
前のコンダクタンス値 TWL変化率=TWL変化量/使用前のTWL値 (評価基準) ○:コンダクタンス変化率+10%以上 △:コンダクタンス変化率+3%以上+10%未満 ×:コンダクタンス変化率+3%以下 ○:TWL変化率+10%以上 △:TWL変化率+3%以上+10%未満 ×:TWL変化率+3%以下"Skin moisturizing effect test" The moisturizing effect on the skin was evaluated using panels of 20 men and women. As an evaluation method, a sample was applied after washing the upper arm, and as described below, changes in TWL and skin conductance before the test were measured to test the moisturizing effect of the skin. The evaluation was performed according to the following evaluation criteria, and the results are shown in Table 3. As is clear from Table 3, it was confirmed that the example of the moisturizing agent of the present invention had a better skin moisturizing effect than the comparative example of the conventional moisturizing agent. Conductance change rate = conductance change amount / conductance value before use TWL change rate = TWL change amount / TWL value before use (Evaluation criteria) :: Conductance change rate + 10% or more △: Conductance change rate + 3% or more + less than 10% ×: Conductance change rate + 3% or less ○: TWL change rate + 10% or more △: TWL change rate + 3% or more and less than + 10% ×: TWL change rate + 3% or less
【0042】[0042]
【表3】 [Table 3]
【0043】「肌あれ改善効果テスト」男女各20人の
パネルを用いて肌荒れ改善効果を評価した。評価方法
は、上腕内側皮膚を3%ドデシル硫酸ナトリウム水溶液
で処理し、肌荒れを作成する。2時間後、表1の試料を
5%水溶液に調整し、40μl開放塗布する。これを5
日間繰り返し、6日目に目視で肌あれ改善効果を判定し
た。判定基準は以下のようであり、評点の低い程、肌荒
れがひどく、評点の高いほど、美しい肌であることを示
す。 (判定基準) 評点1:広範囲の角層の乾燥、めくれ、強い紅斑を認め
る。 評点2:角層の乾燥、めくれ、中程度の紅斑を認める。 評点3:角層の乾燥は認められるが、めくれは認められ
ない。弱い紅斑を認める。 評点4:角層の乾燥、めくれは認められないが、若干の
紅斑を認める。 評点5:かくそうの乾燥、めくれ、紅斑ともに認められ
ない。 評価は該評点を基に平均値で行い、以下の評価基準で判
定し、その結果を表4に示した。表4より明らかなよう
に、従来の保湿剤の比較例に比べて、本発明の保湿剤で
ある実施例の方が優れた肌あれ改善効果を有することが
認められた。 (評価基準) ◎:評点の平均が4以上5以下 ○:評点の平均が3以上4未満 △:評点の平均が2以上3未満 ×:評点の平均が1以上2未満"Skin roughness improvement effect test" The skin roughness improvement effect was evaluated using panels of 20 men and women. In the evaluation method, the inner skin of the upper arm is treated with a 3% aqueous solution of sodium dodecyl sulfate to create rough skin. Two hours later, the samples in Table 1 are adjusted to a 5% aqueous solution, and 40 μl of the sample is open-applied. This is 5
The test was repeated for one day, and on the sixth day, the effect of improving skin roughness was visually determined. The criteria are as follows: the lower the score, the more severe the skin becomes rough, and the higher the score, the more beautiful the skin. (Criterion criteria) Rating 1: Drying, turning over, and strong erythema of a wide range of stratum corneum are recognized. Score 2: Dry, turned-up, moderate erythema of the stratum corneum is recognized. Score 3: Drying of the stratum corneum is observed, but no turning is observed. Weak erythema is observed. Score 4: Drying and turning of the stratum corneum are not recognized, but slight erythema is recognized. Rating 5: Neither dryness, turning over, nor erythema was recognized. The evaluation was carried out by an average value based on the scores, and the evaluation was made according to the following evaluation criteria. The results are shown in Table 4. As is clear from Table 4, it was confirmed that the example of the humectant of the present invention, which is a humectant of the present invention, has a better skin roughness improvement effect than the comparative example of the conventional humectant. (Evaluation criteria) ◎: Average score is 4 or more and 5 or less ○: Average score is 3 or more and less than 4 △: Average score is 2 or more and less than 3 ×: Average score is 1 or more and less than 2
【0044】[0044]
【表4】 [Table 4]
【0045】「肌荒れ改善効果実使用テスト」以下の方
法で実使用用テストを行った。女性健常人の顔面の皮膚
表面形態をシリコン樹脂によるレプリカを作成し、顕微
鏡(17倍)にて観察した。すなわち、皮紋の状態及び
角層の剥離状態から以下に示す基準に基づいて肌荒れ評
価1、2と判断された者(肌荒れパネル)1群10名を
用い、顔面左右半々に以下に示す実施例1〜6及び比較
例1〜7のローションを1日2回塗布した。2週間後、
再びレプリカを採り、肌の状態を前記同様判定した。判
定基準は以下の通りであり、評点の低い程、肌荒れがひ
どく、評点の高いほど、美しい肌であることを示す。 (判定基準) 評点1:皮溝、皮丘の消失。広範囲の角層のめくれ。 評点2:皮溝、皮丘が不鮮明。角層のめくれ。 評点3:皮溝、皮丘が認められるが、平坦。 評点4:皮溝、皮丘が鮮明。 評点5:皮溝、皮丘が鮮明で整っている。 以下の評価基準で判定し、その結果を表5に示した。表
5より明らかなように、従来の保湿剤の比較例に比べ
て、本発明の保湿剤である実施例の方が優れた肌あれ改
善効果を有することが認められた。 (評価基準) ◎:評点4及び5と評価されたパネルの割合が90%以
上 ○:評点4及び5と評価されたパネルの割合が75%以
上90%未満 △:評点4及び5と評価されたパネルの割合が25%以
上75%未満 ×:評点4及び5と評価されたパネルの割合が25%未
満"Surface roughness improvement effect actual use test" An actual use test was conducted by the following method. A replica of the skin surface morphology of the face of a healthy female was made with a silicone resin, and observed with a microscope (17 ×). In other words, the following examples were applied to the left and right half of the face using a group of 10 persons (rough panel) determined to have skin roughness evaluations 1 and 2 based on the following criteria based on the following criteria based on the state of the skin pattern and the peeling state of the stratum corneum. The lotions 1 to 6 and Comparative Examples 1 to 7 were applied twice a day. Two weeks later,
The replica was again taken and the condition of the skin was judged as described above. The criteria are as follows. The lower the score, the more severe the skin becomes rough, and the higher the score, the more beautiful the skin. (Judgment Criteria) Rating 1: Elimination of skin sulcus and skin ridge. Extensive stratum corneum turning. Score 2: Skin grooves and skin hills are unclear. Turn of the stratum corneum. Score 3: Skin grooves and skin ridges were observed, but flat. Score 4: Skin groove and skin hills are clear. Score 5: The skin sulcus and skin hills are clear and well-ordered. The evaluation was made according to the following evaluation criteria, and the results are shown in Table 5. As is clear from Table 5, it was confirmed that the example of the humectant of the present invention, which is a humectant of the present invention, has a better skin roughness improvement effect than the comparative example of the conventional humectant. (Evaluation Criteria) 割 合: The percentage of panels evaluated as 4 and 5 is 90% or more ○: The percentage of panels evaluated as 4 and 5 is 75% or more and less than 90% Δ: Evaluated as 4 and 5 ×: The proportion of panels evaluated as score 4 or 5 is less than 25%.
【0046】[0046]
【表5】 [Table 5]
【0047】「実施例1〜6、比較例1〜6:ローショ
ン」以下のようなローションを常法により製造した。 プロピレングリコール 5.0% クエン酸 4.0 薬剤(表1記載) 3.0 95%エタノール 8.0 POE(20)ラウリルエーテル 2.0 防腐剤・酸化防止剤 適 量 香料 適 量 イオン交換水 残 余"Examples 1 to 6, Comparative Examples 1 to 6: Lotion" The following lotions were produced by a conventional method. Propylene glycol 5.0% Citric acid 4.0 Drugs (described in Table 1) 3.0 95% ethanol 8.0 POE (20) lauryl ether 2.0 Preservatives / antioxidants Appropriate amount Fragrance Appropriate amount Ion-exchanged water residue Extra
【0048】以下に、本発明の保湿剤及び肌あれ改善剤
を用いた皮膚外用剤のその他の実施例を示す。Hereinafter, other examples of a skin external preparation using the humectant and the skin roughness improving agent of the present invention will be described.
【0049】 「実施例7:バニシングクリーム」 ステアリン酸 5.0 ステアリンアルコール 4.0 ステアリン酸ブチルアルコールエステル 8.0 グリセリンモノステアリン酸エステル 2.0 アスコルビン酸ジステアレート 1.0 プロピレングリコール 10.0 モノメチルエリスリトール 1.0 防腐剤・酸化防止剤 適 量 香料 適 量 イオン交換水 残 余 (製法)イオン交換水にモノメチルエリスリトールとプ
ロピレングリコールを加え溶解し、加熱して70℃に保
つ(水相)。他の成分を混合し加熱融解して70℃に保
つ(油相)。上記水相に油相を徐々に加え、全部加え終
わってからしばらくその温度に保ち反応をおこさせる。
その後ホモミキサーで均一に乳化し、よくかきまぜなが
ら、30℃まで冷却する。Example 7: Vanishing cream Stearic acid 5.0 Stearic alcohol 4.0 Stearic acid butyl alcohol ester 8.0 Glycerin monostearate 2.0 Ascorbic acid distearate 1.0 Propylene glycol 10.0 Monomethyl erythritol 1.0 Preservative / Antioxidant Appropriate amount Fragrance Appropriate amount Ion-exchanged water residue (Preparation method) Add monomethylerythritol and propylene glycol to ion-exchanged water, dissolve and heat to 70 ° C (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is gradually added to the water phase, and after the addition is completed, the temperature is maintained for a while to cause a reaction.
Thereafter, the mixture is uniformly emulsified with a homomixer and cooled to 30 ° C. while stirring well.
【0050】 「実施例8:バニシングクリーム」 ステアリン酸 6.0 ソルビタンモノステアリン酸エステル 2.0 ポリオキシエチレン(20モル) ソルビタンモノステアリン酸エステル 1.5 アルブチン 7.0 プロピレングルコール 10.0 モノエチルエリスリトール 5.0 防腐剤・酸化防止剤 適 量 香料 適 量 イオン交換水 残 余 (製法)イオン交換水にモノエチルエリスリトール、ア
ルブチン及びプロピレングリコールを加え加熱して70
℃に保つ(水相)。他の成分を混合し加熱融解して70
℃に保つ(油相)。水相に油相を加え予備乳化を行い、
ホモミキサーで均一に乳化した後、よくかきまぜなが
ら、30℃まで冷却する。Example 8: Vanishing cream Stearic acid 6.0 Sorbitan monostearate 2.0 Polyoxyethylene (20 mol) Sorbitan monostearate 1.5 Arbutin 7.0 Propylene glycol 10.0 Mono Ethyl erythritol 5.0 Preservative / Antioxidant Appropriate amount Fragrance Appropriate amount Ion-exchanged water residue (Preparation method) Add monoethylerythritol, arbutin and propylene glycol to ion-exchanged water and heat.
Keep at ° C (aqueous phase). Mix with other ingredients and heat and melt to 70
C (oil phase). Add oil phase to water phase, pre-emulsify,
After uniformly emulsifying with a homomixer, the mixture is cooled to 30 ° C. while stirring well.
【0051】 「実施例9:中性クリーム」 ステアリルアルコール 7.0 ステアリン酸 2.0 水添ラノリン 2.0 スクワラン 5.0 2−オクチルドデシリアルコール 6.0 ポリオキシエチレン(25モル)セチルアルコールエーテル 3.0 グリセリンモノステアリン酸エステル 2.0 胎盤抽出物 0.1 プロピレングリコール 5.0 メチルエリスリトール(平均置換度n;1.5) 10.0 香料 適 量 防腐剤・酸化防止剤 適 量 イオン交換水 残 余 (製法)イオン交換水にメチルエリスリトール(平均置
換度n;1.5)、胎盤抽出物及びプロピレングリコー
ルを加え加熱して70℃に保つ(水相)。他の成分を混
合し加熱融解して70℃に保つ(油相)。水相に油相を
加え予備乳化を行い、ホモミキサーで均一に乳化した
後、よくかきまぜながら、30℃まで冷却する。Example 9 Neutral Cream Stearyl Alcohol 7.0 Stearic Acid 2.0 Hydrogenated Lanolin 2.0 Squalane 5.0 2-Octyldo Deserial Call 6.0 Polyoxyethylene (25 mol) Cetyl Alcohol ether 3.0 Glycerin monostearate 2.0 Placenta extract 0.1 Propylene glycol 5.0 Methylerythritol (average degree of substitution n; 1.5) 10.0 Perfume Appropriate Preservative / Antioxidant Appropriate Ion-exchanged water Residue (Preparation method) Methylerythritol (average degree of substitution n; 1.5), placenta extract and propylene glycol are added to ion-exchanged water, and heated to 70 ° C. (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is added to the water phase to perform preliminary emulsification, and after uniform emulsification with a homomixer, the mixture is cooled to 30 ° C. while stirring well.
【0052】 「実施例10:コールドクリーム」 固型パラフィン 5.0 蜜ロウ 10.0 ワセリン 15.0 流動パラフィン 41.0 グリセリンモノステアリン酸エステル 2.0 ポリオキシエチレン(20モル) 2.0 ソルビタンモノラウリン酸エステル コウジ酸 2.0 石鹸粉末 0.1 硼砂 0.2 エチルエリスリトールエーテル(平均置換度n;1.3) 0.1 イオン交換水 残 余 香料 適 量 防腐剤・酸化防止剤 適 量 (製法)イオン交換水にエチルエリスリトールエーテル
(平均置換度n;1.3)、コウジ酸、石鹸粉末および
硼砂を加え加熱溶解して70℃に保つ(水相)。他の成
分を混合し加熱融解して70℃に保つ(油相)。水相に
油相をかきまぜながら徐々の加え反応を行う。反応終了
後ホモミキサーで均一に乳化し、乳化後よくかきまぜな
がら30℃まで冷却する。Example 10 Cold Cream Solid Paraffin 5.0 Beeswax 10.0 Vaseline 15.0 Liquid Paraffin 41.0 Glycerin Monostearate 2.0 Polyoxyethylene (20 mol) 2.0 Sorbitan Monolaurate ester Kojic acid 2.0 Soap powder 0.1 Borax 0.2 Ethyl erythritol ether (average degree of substitution n; 1.3) 0.1 Ion-exchange water Residual perfume Appropriate amount Preservative / antioxidant Appropriate amount ( Production method) Ethyl erythritol ether (average degree of substitution n: 1.3), kojic acid, soap powder and borax are added to ion-exchanged water, heated and dissolved, and kept at 70 ° C (aqueous phase). The other components are mixed, melted by heating and kept at 70 ° C. (oil phase). The oil phase is gradually added to the aqueous phase while stirring to carry out the reaction. After the completion of the reaction, the mixture is uniformly emulsified with a homomixer, and cooled to 30 ° C. while stirring well after emulsification.
【0053】 「実施例11:乳 液」 ポリオキシエチレン(20モル) ポリオキシプロピレン(2モル)セチルアルコール 1.0 シリコーンKF96(20cs)(信越化学) 2.0 流動パラフィン(中粘度) 3.0 プロピレングリコール 5.0 アルブチン 2.0 グリセリン 2.0 エチルアルコール 15.0 カルボキシビニルポリマー 0.3 ヒドロキシプロピルセルロース 0.1 2−アミノメチルプロパノール 0.1 防腐剤 適 量 モノメチルエリスリトール・モノメチルトリオトール混合物 20.0 イオン交換水 残 余 (製法)イオン交換水とエタノールにモノメチルエリス
リトール・メチルトリオトール混合物及びアルブチンを
加温溶解し、更にプロピレングリコール以下の水溶性成
分を溶解して、70℃に保つ(水相)。他の油性成分を
混合し、加熱融解して70℃に保つ(油相)。水相に油
相を加え、予備乳化を行い、ホモミキサーで均一乳化
し、乳化後、よくかきまぜながら、30℃まで冷却す
る。Example 11: Emulsion Polyoxyethylene (20 mol) Polyoxypropylene (2 mol) Cetyl alcohol 1.0 Silicone KF96 (20cs) (Shin-Etsu Chemical) 2.0 Liquid paraffin (medium viscosity) 0 Propylene glycol 5.0 Arbutin 2.0 Glycerin 2.0 Ethyl alcohol 15.0 Carboxyvinyl polymer 0.3 Hydroxypropylcellulose 0.1 2-Aminomethylpropanol 0.1 Preservative Appropriate amount Monomethylerythritol / monomethyltriitol mixture 20.0 Ion-exchanged water residue (Preparation method) A mixture of monomethylerythritol / methyltriol and arbutin are heated and dissolved in ion-exchanged water and ethanol, and water-soluble components such as propylene glycol or less are further dissolved and kept at 70 ° C. Aqueous phase) The other oil components are mixed, heated and melted and kept at 70 ° C. (oil phase). The oil phase is added to the water phase, preliminarily emulsified, homogenized with a homomixer, emulsified, and cooled to 30 ° C. while stirring well.
【0054】 「実施例12:乳 液」 ポリオキシエチレン(20モル) ポリオキシプロピレン(2モル)セチルアルコール 1.0 シリコーンKF96(20cs)(信越化学) 2.0 流動パラフィン(中粘度) 3.0 プロピレングリコール 5.0 アスコルビン酸−2−硫酸ナトリウム 5.0 グリセリン 2.0 エチルアルコール 15.0 カルボキシビニルポリマー 0.3 ヒドロキシプロピルセルロース 0.1 2−アミノメチルプロパノール 0.1 防腐剤 適 量 モノエチルエリスリトール・モノエチルトレオトール混合物 7.0 イオン交換水 残 余 (製法)イオン交換水とエタノールにモノエチルエリス
リトール・モノエチルトレオトール混合物を加温溶解
し、更にプロピレングリコール以下の水溶性成分を溶解
して、70℃に保つ(水相)。他の油性成分を混合し、
加熱融解して70℃に保つ(油相)。水相に油相を加
え、予備乳化を行い、ホモミキサーで均一に乳化し、乳
化後、よくかきまぜながら、30℃まで冷却する。“Example 12: Emulsion” Polyoxyethylene (20 mol) Polyoxypropylene (2 mol) Cetyl alcohol 1.0 Silicone KF96 (20cs) (Shin-Etsu Chemical) 2.0 Liquid paraffin (medium viscosity) 0 Propylene glycol 5.0 Sodium ascorbic acid-2-sulfate 5.0 Glycerin 2.0 Ethyl alcohol 15.0 Carboxyvinyl polymer 0.3 Hydroxypropylcellulose 0.1 2-Aminomethylpropanol 0.1 Preservative Suitable amount Mono Ethyl erythritol / monoethyl threitol mixture 7.0 Ion-exchanged water residue (Preparation method) Heat-dissolve the monoethyl erythritol / monoethylthreitol mixture in ion-exchanged water and ethanol, and further dissolve water-soluble components below propylene glycol To 70 ° C One (aqueous phase). Mix with other oily ingredients,
Heat to melt and maintain at 70 ° C (oil phase). The oil phase is added to the water phase, preliminarily emulsified, and uniformly emulsified by a homomixer. After emulsification, the mixture is cooled to 30 ° C. while stirring well.
【0055】 「実施例13:乳 液」 ポリオキシエチレン(20モル) ポリオキシプロピレン(2モル)セチルアルコール 1.0 シリコーンKF96(20cs)(信越化学) 2.0 流動パラフィン(中粘度) 3.0 プロピレングリコール 5.0 グリセリン 2.0 エチルアルコール 15.0 カルボキシビニルポリマー 0.3 ヒドロキシプロピルセルロース 0.1 2−アミノメチルプロパノール 0.1 防腐剤 適 量 胎盤抽出物 5.0 メチルエリスリトール(平均置換度n;1.8) 7.0 イオン交換水 残 余 (製法)イオン交換水とエタノールにメチルエリスリト
ール(平均置換度n;1.8)および胎盤抽出物を加温
溶解し、更にプロピレングリコール以下の水溶性成分を
溶解して、70℃に保つ(水相)。他の油性成分を混合
し、加熱融解して70℃に保つ(油相)。水相に油相を
加え、予備乳化を行い、ホモミキサーで均一に乳化し、
乳化後、よくかきまぜながら、30℃まで冷却する。Example 13: Emulsion Polyoxyethylene (20 mol) Polyoxypropylene (2 mol) Cetyl alcohol 1.0 Silicone KF96 (20cs) (Shin-Etsu Chemical) 2.0 Liquid paraffin (medium viscosity) 0 Propylene glycol 5.0 Glycerin 2.0 Ethyl alcohol 15.0 Carboxyvinyl polymer 0.3 Hydroxypropylcellulose 0.1 2-Aminomethylpropanol 0.1 Preservative Appropriate amount Placental extract 5.0 Methyl erythritol (average substitution) Degree n; 1.8) 7.0 Ion-exchanged water residue (Preparation method) Methylerythritol (average degree of substitution n; 1.8) and placenta extract are dissolved by heating in ion-exchanged water and ethanol, and propylene glycol or less Are dissolved and kept at 70 ° C. (aqueous phase). The other oil components are mixed, heated and melted and kept at 70 ° C. (oil phase). Add oil phase to water phase, pre-emulsify, homogenize uniformly with homomixer,
After emulsification, cool to 30 ° C while stirring well.
【0056】 「実施例14:乳 液」 ポリオキシエチレン(20モル) ポリオキシプロピレン(2モル)セチルアルコール 1.0 シリコーンKF96(20cs)(信越化学) 2.0 流動パラフィン(中粘度) 3.0 プロピレングリコール 5.0 グルセリン 2.0 エチルアルコール 15.0 カルボキシビニルポリマー 0.3 ヒドロキシプロピルセルロース 0.1 2−アミノメチルプロパノール 0.1 防腐剤 適 量 コウジ酸 3.0 エチルエリスリトール(平均置換度n;1.2) 3.0 イオン交換水 残 余 (製法)イオン交換水とエタノールにエチルエリスリト
ール(平均置換度n;1.2)およびコウジ酸を加温溶
解し、更にプロピレングリコール以下の水溶性成分を溶
解して、70℃に保つ(水相)。他の油性成分を混合
し、加熱融解して70℃に保つ(油相)。水相に油相を
加え、予備乳化を行い、ホモミキサーで均一に乳化し、
乳化後、よくかきまぜながら、30℃まで冷却する。Example 14: Emulsion Polyoxyethylene (20 mol) Polyoxypropylene (2 mol) Cetyl alcohol 1.0 Silicone KF96 (20cs) (Shin-Etsu Chemical) 2.0 Liquid paraffin (medium viscosity) 0 Propylene glycol 5.0 Glucerin 2.0 Ethyl alcohol 15.0 Carboxyvinyl polymer 0.3 Hydroxypropylcellulose 0.1 2-Aminomethylpropanol 0.1 Preservative Appropriate amount Kojic acid 3.0 Ethyl erythritol (Average degree of substitution n; 1.2) 3.0 ion-exchanged water residue (Preparation method) Ethyl erythritol (average degree of substitution n; 1.2) and kojic acid are dissolved by heating in ion-exchanged water and ethanol, and further, an aqueous solution of propylene glycol or less Dissolve the acidic components and maintain at 70 ° C. (aqueous phase). The other oil components are mixed, heated and melted and kept at 70 ° C. (oil phase). Add oil phase to water phase, pre-emulsify, homogenize uniformly with homomixer,
After emulsification, cool to 30 ° C while stirring well.
【0057】 「実施例15:乳 液」 ステアリン酸 1.5 セチルアルコール 0.5 蜜ロウ 2.0 ポリオキシエチレン(20モル)モノオレイン酸エステル 1.0 グリセリンモノステアリン酸エステル 1.0 クインスシード抽出液(5%水溶液) 20.0 エチルアルコール 10.0 アルブチン 20.0 プロピレングリコール 5.0 ブチルエリスリトール(平均置換度n;0.8) 3.0 イオン交換水 残 余 香料 適 量 防腐剤・酸化防止剤 適 量 (製法)イオン交換水にブチルエリスリトール(平均置
換度n;0.8)、アルブチン及びプロピレングリコー
ルを加え加熱溶解して70℃に保つ(水相)。エチルア
ルコールに香料を加えて溶解する(アルコール相)。ク
インスシード抽出液を除く他の成分を混合し加熱融解し
て70℃に保つ(油相)。水相に油相を加え予備乳化を
行いホモミキサーで均一に乳化する。これをかきまぜな
がらアルコール相とクインスシード抽出液を加える。そ
の後かきまぜながら30℃まで冷却する。Example 15 Emulsion 1.5 Stearic Acid 1.5 Cetyl Alcohol 0.5 Beeswax 2.0 Polyoxyethylene (20 mol) Monooleate 1.0 Glycerin Monostearate 1.0 Quince Seed Extract (5% aqueous solution) 20.0 Ethyl alcohol 10.0 Arbutin 20.0 Propylene glycol 5.0 Butyl erythritol (Average degree of substitution n; 0.8) 3.0 Ion-exchanged water Residual perfume Appropriate preservative Antioxidant Appropriate amount (Preparation method) Add butylerythritol (average degree of substitution n: 0.8), arbutin and propylene glycol to ion-exchanged water, dissolve by heating, and maintain at 70 ° C (aqueous phase). Add flavor to ethyl alcohol and dissolve (alcohol phase). Other components except the quince seed extract are mixed, heated and melted, and kept at 70 ° C. (oil phase). The oil phase is added to the water phase, pre-emulsified, and homogenized uniformly with a homomixer. While stirring, add the alcohol phase and the quince seed extract. Then, cool to 30 ° C with stirring.
【0058】 「実施例16:乳 液」 マイクロクリスタリンワックス 1.0 蜜ロウ 2.0 ラノリン 2.0 流動パラフィン 20.0 スクワラン 10.0 ソルビタンセスキオレイン酸エステル 4.0 ポリオキシエチレン(20モル) 1.0 ソルビタンモノオレイン酸エステル アルブチン 5.0 コウジ酸 5,0 プロピレングリコール 7.0 メチルエリスリトール・メチルトレオトール混合物 2.0 (平均置換度n;1.6) イオン交換水 残 余 香料 適 量 防腐剤・酸化防止剤 適 量 (製法)イオン交換水にメチルエリスリトール・メチル
トレオトール混合物2.0(平均置換度n;1.6)、
アルブチン、コウジ酸及びプロピレングリコールを加え
加熱して70℃に保つ(水相)。他の成分を混合し加熱
溶解して70℃に保つ(油相)。油相をかきまぜなが
ら、この油相に水相を徐々に加え、ホモミキサーで均一
に乳化する。乳化後よくかきまぜながら30℃まで冷却
する。Example 16: Emulsion Microcrystalline wax 1.0 Beeswax 2.0 Lanolin 2.0 Liquid paraffin 20.0 Squalane 10.0 Sorbitan sesquioleate 4.0 Polyoxyethylene (20 mol) 1.0 Sorbitan monooleate Arbutin 5.0 Kojic acid 5,0 Propylene glycol 7.0 Mixture of methylerythritol / methylthreitol 2.0 (Average degree of substitution n; 1.6) Ion-exchanged water Residual perfume Appropriate amount Preservative / Antioxidant Appropriate amount (Preparation method) Methylerythritol / methylthreitol mixture 2.0 (average degree of substitution n; 1.6) in ion-exchanged water,
Arbutin, kojic acid and propylene glycol are added and heated to 70 ° C. (aqueous phase). The other components are mixed, dissolved by heating and kept at 70 ° C. (oil phase). While stirring the oil phase, the aqueous phase is gradually added to the oil phase, and the mixture is uniformly emulsified with a homomixer. After emulsification, cool to 30 ° C with good stirring.
【0059】 「実施例17:ゼリー」 95%エチルアルコール 10.0 ジプロピレングリコール 15.0 ポリオキシエチレン(15モル)オレイルアルコールエーテル 2.0 アルブチン 0.5 アスコルビン酸ジステアレ−ト 0.5 カルボキシビニルポリマー(商品名:カーボポール941) 1.0 苛性カリ 0.15 L−アルギニン 0.1 ヒドロキシエチルトレオトール(平均置換度n;1.3) 2.0 メチルエリスリトール(平均置換度n;1.5) 1.0 香料 適 量 防腐剤 適 量 イオン交換水 残 余 (製法)イオン交換水にヒドロキシエチルトレオトール
(平均置換度n;1.3)、メチルエリスリトール(平
均置換度n;1.5)、アルブチン及びカーボポール9
41を均一に溶解し、一方95%エタノールにジプロピ
レングリコール、ポリオキシエチレン(15モル)オレ
イルアルコールエーテル、その他の成分を溶解し、水相
に添加する。ついで苛性カリ、L−アルギニンで中和さ
せ増粘する。Example 17 Jelly 95% ethyl alcohol 10.0 dipropylene glycol 15.0 polyoxyethylene (15 mol) oleyl alcohol ether 2.0 arbutin 0.5 ascorbic acid distearate 0.5 carboxyvinyl Polymer (trade name: Carbopol 941) 1.0 Caustic potash 0.15 L-arginine 0.1 Hydroxyethylthreitol (average degree of substitution n; 1.3) 2.0 Methylerythritol (average degree of substitution n; 1.5) 1.0 1.0 Perfume Appropriate amount Preservative Appropriate amount Ion-exchange water residue (Preparation method) Hydroxyethylthreitol (average degree of substitution n; 1.3), methylerythritol (average degree of substitution n; 1.5) in ion-exchanged water , Arbutin and Carbopol 9
41 is dissolved uniformly, while dipropylene glycol, polyoxyethylene (15 mol) oleyl alcohol ether and other components are dissolved in 95% ethanol and added to the aqueous phase. Then, it is neutralized with caustic potash and L-arginine to increase the viscosity.
【0060】 「実施例18:ピールオフ型パック」 (アルコール相) 95%エタノール 10.0 ポリオキシエチレン(15モル)オレイルアルコールエーテル 2.0 防腐剤 適 量 香 料 適 量 (水相) モノエチルエリスリトール・モノエチルトレオトール混合物 4.0 アルブチン 1.0 ポリビニルアルコール 12.0 グリセリン 3.0 ポリエチレングリコール1500 1.0 イオン交換水 残 余 (製法)80℃にて水相を調製し、50℃に冷却する。
ついで室温で調製したアルコール相を添加後均一に混合
し、放冷する。“Example 18: Peel-off type pack” (alcohol phase) 95% ethanol 10.0 polyoxyethylene (15 mol) oleyl alcohol ether 2.0 preservative appropriate amount perfume appropriate amount (aqueous phase) monoethyl erythritol・ Monoethylthreitol mixture 4.0 Arbutin 1.0 Polyvinyl alcohol 12.0 Glycerin 3.0 Polyethylene glycol 1500 1.0 Ion-exchanged water Residue (Preparation method) Prepare an aqueous phase at 80 ° C and cool to 50 ° C I do.
Then, the alcohol phase prepared at room temperature is added, mixed uniformly, and left to cool.
【0061】 「実施例19:粉末入りパック」 (アルコール相) 95%エタノール 2.0 防腐剤 適 量 香 料 適 量 色 剤 適 量 アスコルビン酸ジオレ−ト 1.0 (水相) エチルトレオトール(平均置換度n;1.3) 7.0 アルブチン 1.0 プロピレングリコール 7.0 亜鉛華 25.0 カオリン 20.0 イオン交換水 残 余 (製法)室温にて水相を均一に調製する。ついで室温に
て調製したアルコール相を添加し均一に混合する。“Example 19: Pack with powder” (Alcohol phase) 95% ethanol 2.0 Preservatives Appropriate amount Flavors Appropriate amount Colorant Appropriate amount Ascorbic acid diolate 1.0 (Aqueous phase) Ethylthreitol ( Average substitution degree n; 1.3) 7.0 Arbutin 1.0 Propylene glycol 7.0 Zinc white 25.0 Kaolin 20.0 Ion-exchanged water Residue (Preparation method) An aqueous phase is uniformly prepared at room temperature. Then, the alcohol phase prepared at room temperature is added and mixed uniformly.
【0062】 「実施例20:吸水軟膏」 ワセリン 40.0 ステアリルアルコール 18.0 モクロウ 20.0 ポリオキシエチレン(10モル)モノオレイン酸エステル 0.25 ヒドロキシエチルエリスリトール(平均置換度n;1.5) 0.25 胎盤抽出物 1.0 バリングリセリンエステル・塩酸塩 10.0 イオン交換水 残 余 (製法)イオン交換水にヒドロキシエチルエリスリトー
ル(平均置換度n;1.5)、胎盤抽出物を加え、70
℃に保つ(水相)。他の成分を70℃にて混合溶解する
(油相)。上記水相に油相を添加し、ホモミキサーで均
一に乳化後、冷却する。“Example 20: Water-absorbing ointment” Vaseline 40.0 Stearyl alcohol 18.0 Mokurou 20.0 Polyoxyethylene (10 mol) monooleate 0.25 Hydroxyethyl erythritol (Average degree of substitution n: 1.5 0.25 Placental extract 1.0 Baringlyserine ester / hydrochloride 10.0 Ion-exchanged water residue (Preparation method) Add hydroxyethylerythritol (average degree of substitution n; 1.5) and placenta extract to ion-exchanged water , 70
Keep at ° C (aqueous phase). Other components are mixed and dissolved at 70 ° C. (oil phase). The oil phase is added to the aqueous phase, and the mixture is uniformly emulsified with a homomixer and then cooled.
【0063】本発明で得られた皮膚外用剤はいずれも実
施例1〜6で行った肌荒れ改善効果実使用テストにおい
て肌あれ改善効果が認められた。The skin external preparations obtained in the present invention all showed skin roughening improvement effects in the actual use test conducted in Examples 1 to 6 in which the skin roughening improvement effect was recognized.
【0064】[0064]
【発明の効果】本発明によれば、優れた保湿効果及び肌
あれ改善効果を有する新規な保湿剤及び肌あれ改善剤を
提供出来る。また、安全性が高く、優れた保湿効果及び
肌あれ改善効果を有しかつ使用性に優れた皮膚外用剤を
提供出来る。According to the present invention, it is possible to provide a novel moisturizing agent and a skin roughness improving agent having an excellent moisturizing effect and a skin roughness improving effect. In addition, it is possible to provide a skin external preparation that is highly safe, has an excellent moisturizing effect and a skin roughness improvement effect, and is excellent in usability.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 中島 英夫 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hideo Nakajima 1050 Nippa-cho, Kohoku-ku, Yokohama-shi, Kanagawa Inside Shiseido Daiichi Research Center Co., Ltd.
Claims (3)
ルテトリトールエーテルを有効成分とすることを特徴と
する保湿剤。 【化1】A−Rn (1) (Aは水素原子nを除いたテトリトール残基を表し、R
は炭素数1〜4のアルキル基で、直鎖アルキル基、分岐
アルキル基、不飽和アルキル基、ヒドロキシアルキル基
のいずれでも良い。nはRの平均置換度を表し、1〜4
の範囲の数である。)1. A humectant comprising a lower alkyl tetritol ether represented by the following general formula (1) as an active ingredient. A-Rn (1) (A represents a tetritol residue excluding a hydrogen atom n;
Is an alkyl group having 1 to 4 carbon atoms, and may be any of a linear alkyl group, a branched alkyl group, an unsaturated alkyl group, and a hydroxyalkyl group. n represents the average degree of substitution of R;
Is a number in the range. )
ルエーテルを有効成分とすることを特徴とする肌あれ改
善剤。2. A skin roughness improving agent comprising the lower alkyl tetritol ether according to claim 1 as an active ingredient.
ルエーテルを含有することを特徴とする皮膚外用剤。3. An external preparation for skin, comprising the lower alkyl tetritol ether according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20715097A JP3611164B2 (en) | 1997-07-16 | 1997-07-16 | Moisturizer, skin remedy, and skin external preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20715097A JP3611164B2 (en) | 1997-07-16 | 1997-07-16 | Moisturizer, skin remedy, and skin external preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH1135443A true JPH1135443A (en) | 1999-02-09 |
JP3611164B2 JP3611164B2 (en) | 2005-01-19 |
Family
ID=16535053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20715097A Expired - Fee Related JP3611164B2 (en) | 1997-07-16 | 1997-07-16 | Moisturizer, skin remedy, and skin external preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3611164B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093329A1 (en) * | 2005-03-03 | 2006-09-08 | Shiseido Company, Ltd. | Antimicrobial agent |
JP2006241074A (en) * | 2005-03-03 | 2006-09-14 | Shiseido Co Ltd | External composition for skin |
WO2009063644A1 (en) * | 2007-11-14 | 2009-05-22 | Shiseido Company, Ltd. | External preparation for the skin |
CN113604296A (en) * | 2021-08-30 | 2021-11-05 | 纳爱斯浙江科技有限公司 | Detergent composition with low irritation, high cleaning power and low temperature stability |
-
1997
- 1997-07-16 JP JP20715097A patent/JP3611164B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093329A1 (en) * | 2005-03-03 | 2006-09-08 | Shiseido Company, Ltd. | Antimicrobial agent |
JP2006241074A (en) * | 2005-03-03 | 2006-09-14 | Shiseido Co Ltd | External composition for skin |
WO2009063644A1 (en) * | 2007-11-14 | 2009-05-22 | Shiseido Company, Ltd. | External preparation for the skin |
JP2009120527A (en) * | 2007-11-14 | 2009-06-04 | Shiseido Co Ltd | Skin care preparation for external use |
CN113604296A (en) * | 2021-08-30 | 2021-11-05 | 纳爱斯浙江科技有限公司 | Detergent composition with low irritation, high cleaning power and low temperature stability |
CN113604296B (en) * | 2021-08-30 | 2023-09-12 | 纳爱斯浙江科技有限公司 | Detergent composition with low irritation, high cleaning power and low-temperature stability |
Also Published As
Publication number | Publication date |
---|---|
JP3611164B2 (en) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4766153A (en) | Alkyl polyoxyalkylene carboxylate esters and skin care compositions containing the same | |
JPS6037087B2 (en) | cosmetics | |
JPS6334851B2 (en) | ||
US4032676A (en) | N-polyhydroxyalkyl-amino acids, their manufacture and skin treating agents containing the same | |
JP2946145B2 (en) | Cosmetics | |
FR2694289A1 (en) | Sulfurous, fluorinated and polyglycerolated amphiphilic compounds, cosmetic or pharmaceutical composition comprising them, process for their preparation and vesicles formed | |
GB2130206A (en) | Glyceryl glycerine hydroxy ether compounds | |
JP3611164B2 (en) | Moisturizer, skin remedy, and skin external preparation | |
JP7267657B1 (en) | Ascorbic acid derivatives or salts thereof and cosmetics thereof | |
JP4658898B2 (en) | Melanin inhibitor and whitening cosmetic | |
KR101002432B1 (en) | Resveratrol derivative, preparation method thereof, and cosmetic composition comprising same | |
JP3457813B2 (en) | Cosmetics | |
JP2962366B2 (en) | External preparation for skin | |
JPH05124921A (en) | Cosmetic | |
WO2024111142A1 (en) | Ascorbic acid derivative or salt thereof, and cosmetic thereof | |
JP2003201264A (en) | Hinokitiol derivative and skin care preparation and hair cosmetic containing the same | |
JP5778134B2 (en) | Topical skin preparation | |
JPS62205187A (en) | Liquid crystal composition | |
JP2704759B2 (en) | Glyceryl ether derivative and external preparation for skin containing the same | |
JP2879584B2 (en) | Maltitol aliphatic ether | |
JP2691609B2 (en) | Emulsified cosmetic | |
JPH06227958A (en) | External agent for skin | |
JPH08269077A (en) | Beta-hydroxyalkyl glycoside and dermal preparation for external use containing the same ans detergent composition containing the same | |
JPH09176097A (en) | Production of (2s,3s)-2-aminoalkane-1,3-diols | |
JPS647061B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040820 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041005 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20041014 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081029 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091029 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091029 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101029 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101029 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111029 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121029 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131029 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |